The role of healthcare strategies in controlling antibiotic resistance

British Journal of Nursing

Volumn 22, Issue 18, 2013, Pages 1066-1074

  Aziz, Ann Marie ^a  

^a PENNINE CARE NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Antibiotics; Bacteria; Infection control; Prevention; Resistance

Indexed keywords

EID: 84885579896     PISSN: 09660461     EISSN: None     Source Type: Journal    
DOI: 10.12968/bjon.2013.22.18.1066     Document Type: Article

References (62)

1. Albert HB, Lambert P, Rollason J et al (2013) Does nuclear tissue infected with bacteria following disc herniations lead to Modic changes in the adjacent vertebrae? Eur Spine J 22(4): 690-6
2. Aldeyab MA, Kearney MP, McElnay JC et al (2011) A point prevalence survey of antibiotic prescriptions: benchmarking and patterns of use. Br J Clin Pharmacol 71(2): 293-6
3. Ashley DJ, Brindle MJ (1960) Penicillin resistance in staphylococci isolated in a casualty department. J Clin Path 13: 336-8
4. Barlow G, Nathwani D (2005) Is antibiotic resistance a problem? A practical guide for hospital clinicians. Postgrad Med J 81(961): 680-92
5. Bennett PM (2008) Plasmid encoded antibiotic resistance: acquisition and transfer of antibiotic resistance genes in bacteria. Br J Pharmacol 153(S1): S347-57
6. Butler CC, Simpson SA, Dunstan F et al (2012) Effectiveness of multifaceted educational programme to reduce antibiotic dispensing in primary care: practice based randomised controlled trial BMJ 344: d8173
7. Chalmers JD, Al-Khairalla M, Short PM et al (2010) Proposed changes to management of lower respiratory tract infections in response to the Clostridium difficile epidemic. J Antimicrob Chemother 65(4): 608-18
8. Choudhury G, Mandal P, Singanayagam A et al (2011) Seven-day antibiotic courses have similar efficacy to prolonged courses in severe communityacquired pneumonia - a propensity-adjusted analysis. Clin Microbiol Infect 17(2): 1852-8
9. Coates AR, Halls G, Hu Y (2011) Novel classes of antibiotics or more of the same? Br J Pharmacol 163(1): 184-94
10. Davey P, Brown E, Fenelon L et al (2005) Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev 4: CD003543
11. Davey P, Brown E, Charani E et al (2013) Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev 4: CD003543
12. Department of Health (2003) Nurse Prescribers Extended Formulary: proposals to extend range of prescription only medicines. Letter. http://tinyurl.com/ peo7ghh (accessed 27 September 2013)
13. Department of Health (2008) The Health and Social Care Act 2008. Code of Practice on the Prevention and Control of Infections and Related guidance. Department of Health, London. http://tinyurl.com/n3yklv5 (accessed 27 September 2013)
14. Department of Health (2010) Department of Health Key Messages. Antibiotic Resistance. EU Antibiotic Awareness Day 18 Nov. Department of Health, London. http://tinyurl.com/po7rkuj (accessed 27 September 2013)
15. Department of Health (2011) Annual Report of the Chief Medical Officer, Volume Two, 2011. Infections and the Rise of Antimicrobial Resistance. Department of Health, London. http://tinyurl.com/m9yx4fl (accessed 27 September 2013)
16. Department of Health (2013) Prevention and Control of Infection in Care Homes - an Information Resource. Department of Health, London. http://tinyurl.com/ p9l5r6r (accessed 27 September 2013)
17. Delepierre A, Gayot A, Carpentier A (2012) Update on counterfeit antibiotics worldwide; public health risks. Med Mal Infect 42(6): 247-55
18. European Centre for Disease Prevention and Control. (2009) The Bacterial Challenge: Time to React. European Centre for Disease Prevention and Control, Stockholm. http://tinyurl.com/p8c272x (accessed 27 September 2013)
19. Finch R, Hunter PA (2006) Antibiotic resistance - action to promote new technologies: report of an EU Intergovernmental Conference held in Birmingham, UK, 12-13 December 2005. J Antimicrob Chemother 58(Suppl 1): i3-22
20. Gandhi NR, Moll A, Sturm AW et al (2006) Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 368: 1575-80
21. Gould IM (2005) The clinical significance of methicillin-resistant Staphylococcus aureus. J Hosp Infect 61(4): 277-82
22. Grossman RF (1998) The value of antibiotics and the outcomes of antibiotic therapy in exacerbations of COPD. Chest 113(4 Suppl): 249S-55
23. Hairon N (2008) Reducing antibiotic use in the fight against MRSA. Nurs Times 104(6): 23-4
24. Health Protection Agency (2011) Advice on Carbapenemase Producers: Recognition, Infection Control and Treatment. Health Protection Agency, London. http:// tinyurl.com/pxd8x28 (accessed 27 September 2013)
25. Health Protection Agency (2012) English National Point Prevalence Survey on Healthcare-associated Infections and Antimicrobial Use, 2011. Preliminary Data. Health Protection Agency, London. http://tinyurl.com/blwmzug (accessed 27 September 2013)
26. Högberg LD, Heddini A, Cars O (2010) The global need for effective antibiotics: challenges and recent advances. Trends Pharmacol Sci 31(11): 509-15
27. Jassal M, Bishai WR (2009) Extensively drug-resistant tuberculosis. Lancet Infect Dis 9(1): 19-30
28. Jeanes A (2004) Keeping hospitals clean: how nurses can reduce health-careassociated infection. Nurs Times 1 Feb. http://tinyurl.com/p7ck9c3 (accessed 27 September 2013)
29. Kelly J (2001) Addressing the problem of increased antibiotic resistance. Nurs Times 1 Sept. http://tinyurl.com/qfl8m3p (accessed 27 September 2013)
30. Knapp CW, Dolfing J, Ehlert PA, Graham DW (2010) Evidence of increasing antibiotic resistance gene abundances in archived soils since 1940. Environ Sci Technol 44(2): 580-7
31. Lesprit P, Brun-Buisson C (2008) Hospital antibiotic stewardship. Curr Opin Infect Dis 21(4): 344-9
32. Loveday HP (2007) Putting the epic2 infection control guidelines into practice. Nurs Times 103(33): 30-1. http://tinyurl.com/pwhsjdz (accessed 27 September 2013)
33. McClenny N (2005) Laboratory detection and identification of Aspergillus species by microscopic observation and culture: the traditional approach. Med Mycol 43(Suppl 1): S125-8
34. McCormack J, Allan GM (2012) A prescription for improving antibiotic prescribing in primary care. BMJ 344: d7955
35. NHS Choices (2013) Superbug threat is ?ticking time bomb?. http://tinyurl.com/ njsm5sr (accessed 27 September 2013)
36. National Institute for Health and Care Excellence (2008) Respiratory Tract Infections - Antibiotic Prescribing. Prescribing of Antibiotics for Self-limiting Respiratory Tract Infections in Adults and Children in Primary Care. NICE, London. www.nice.org. uk/cg69 (accessed 27 September 2013)
37. Nguyen L, Thompson CJ (2006) Foundations of antibiotic resistance in bacterial physiology: the mycobacterial paradigm. Trends Microbiol 14(7): 304-12
38. Omilusik K (2004) From dyes to peptides: the evolution of antibiotic drugs. Science Creative Quarterly http://tinyurl.com/pbcu28x (accessed 27 September 2013)
39. Perry C, Hall C (2009) Antibiotic resistance: how it arises, the current position and future strategies. Nurs Times 105(36): 20-3. http://www. nursingtimes. net/antibiotic-resistance-how-it-arises-the-current-position-and- futurestrategies/ 5006184.article (accessed 27 September 2013)
40. Pittet D, Hugonnet S, Harbarth S et al (2000) Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme. Lancet 356(9238): 1307-12
41. Pratt RJ, Pellowe C, Loveday HP et al (2001) The epic project: developing national evidence-based guidelines for preventing healthcare associated infections. Phase I: Guidelines for preventing hospital-acquired infections. Department of Health (England). J Hosp Infect 47(Suppl): S3-82
42. Pratt RJ, Pellowe CM, Wilson JA et al (2007) epic2: National evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect 65(Suppl 1): S1-64
43. Salmon D (2013) Patients with coughs don?t need antibiotics - pass it on. BMJ 346: f254
44. Scottish Antimicrobial Prescribing Group (2010) Surveillance of Antimicrobial Use and Resistance: Guidance for Antimicrobial Management Teams. Scottish Medicines Consortium, Glasgow. http://tinyurl.com/ot4c388 (accessed 27 September 2013)
45. Sidjabat HE, Kamolvit W, Wailan A, Paterson DL (2013) Multi-drug-resistant Gram-negative bacteria. Microbiol Australia 34(1):43-6. http://tinyurl.com/ os33elr (accessed 27 September 2013)
46. Smith R, Coast J (2013a) The true cost of antimicrobial resistance. BMJ 346: f1493
47. Smith R, Coast J (2013b) The economic burden of antimicrobial resistance: Why it is more serious than current studies suggest. http://tinyurl.com/ pxvxow8= (accessed 27 September 2013)
48. Souli M, Galani I, Giamarellou H (2008) Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe. Euro Surveill 13(47): pii: 19045
49. Spellberg B, Powers JH, Brass EP et al (2004) Trends in antimicrobial drug development: implications for the future. Clin Infect Dis 38(9): 1279-86
50. Storr J, Gallagher R (2012) Cutting levels of antimicrobial resistance. Nurs Times 108(46): 22-3
51. The Economist (2012) The path of least resistance. www.economist.com/ node/21554542 (accessed 27 September 2013)
52. Wallinga D, Burch DG (2013) Does adding routine antibiotics to animal feed pose a serious risk to human health? BMJ 347: f4214
53. Walsh F (2013) Antibiotics resistance ?as big a risk as terrorism? - medical chief. BBC News, 11 March. www.bbc.co.uk/news/health-21737844 (accessed 27 September 2013)
54. Watson R (2008) Multidrug resistance responsible for half of deaths from healthcare associated infections in Europe. BMJ 36(7656): 1266-7
55. Welschen I, Kuyvenhoven MM, Hoes AW, Verheij TJ (2004) Effectiveness of a multiple intervention to reduce antibiotic prescribing for respiratory tract symptoms in primary care: randomised controlled trial. BMJ 329: 431
56. Wenzel RP (2004) The antibiotic pipeline - challenges, costs, and values. New Engl J Med 351(6): 523-6
57. Willemsen I, Groenhuijzen A, Bogaers D et al (2007) Appropriateness of antimicrobial therapy measured by repeated prevalence surveys. Antimicrob Agents Chemother 51(3): 864-7
58. Wilton P, Smith R, Coast J, Millar M (2002) Strategies to contain the emergence of antimicrobial resistance: a systematic review of effectiveness and costeffectiveness. J Health Serv Res Policy 7(2): 111-7
59. Wise J (2013) Study proposes antibiotics as possible new treatment for some types of chronic low back pain. BMJ 346: f2988
60. Wolff KA, Sherman M, Nguyen L (2011) Potentiation of available antibiotics by targeting resistance - an emerging trend in tuberculosis drug development. In: Rundfeldt C, ed. Drug Development - A Case Study Based Insight into Modern Strategies. InTech Europe, Rijeka, Croatia. http://tinyurl.com/ pksdoy9 (accessed 27 September 2013)
61. World Health Organization (2010) Tuberculosis Fact Sheet. World Health Organization, Geneva. www.who.int/mediacentre/factsheets/fs104 (accessed 27 September 2013)
62. World Health Organization (2012) The Evolving Threat of Antimicrobial Resistance: Options for Action. World Health Organization, Geneva. http://tinyurl.com/blhxofz (accessed 27 September 2013)